...
首页> 外文期刊>Analytica chimica acta >Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors
【24h】

Design of a dual aptamer-based recognition strategy for human matrix metalloproteinase 9 protein by piezoelectric biosensors

机译:基于双适体的压电生物传感器对人基质金属蛋白酶9蛋白的识别策略设计

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

MMP-9, human matrix metalloproteinase 9, belongs to the family of zinc-dependent peptide-bond hydrolases and is involved in the degradation of the extracellular matrix (ECM). In clinics, it is well known that elevated MMP-9 serum levels are associated with cardiovascular dysfunctions, several aspects of the physiology and pathology of the central nervous system, neuropsychiatric disorders and degenerative diseases related to brain tumors, and excitotoxiceuroinflammatory processes. Due to the large interest of diagnostics in this protein, efforts to set up sensitive methods to detect MMP-9 for early diagnosis of a number of metabolic alterations are rapidly increasing. In this panorama, biosensors could play a key role; therefore we explored for the first time the development of an aptamer-based piezoelectric biosensor for a sensitive, label free, and real time detection of MMP-9. The detecting strategy involved two different aptamers in a sandwich-like approach able to detect down to 100 pg mL(-1) (1.2 pM) of MMP-9 as detection limit in standard solution. As proof of principle, commercial serum was investigated in terms of possible interferents, their identification and role in MMP-9 detection. The estimated detection limit for MMP-9 is about 560 pg mL(-1) (6.8 pM) in untreated serum. (C) 2015 Elsevier B.V. All rights reserved.
机译:MMP-9,人类基质金属蛋白酶9,属于锌依赖性肽键水解酶家族,参与细胞外基质(ECM)的降解。在临床上,众所周知的是,MMP-9血清水平升高与心血管功能障碍,中枢神经系统生理学和病理学,神经精神疾病和与脑肿瘤有关的退行性疾病以及兴奋性毒性/神经炎性过程的多个方面有关。由于对这种蛋白质的诊断方法的极大兴趣,建立用于检测MMP-9以便早期诊断许多代谢变化的敏感方法的努力正在迅速增加。在这个全景图中,生物传感器可以发挥关键作用;因此,我们首次探索了基于适体的压电生物传感器的开发,该传感器可对MMP-9进行灵敏,无标记的实时检测。该检测策略以三明治式方法涉及两种不同的适体,能够检测低至100 pg mL(-1)(1.2 pM)的MMP-9作为标准溶液中的检测限。作为原理证明,从可能的干扰物,其识别和在MMP-9检测中的作用方面研究了商业血清。在未经处理的血清中,MMP-9的估计检出限约为560 pg mL(-1)(6.8 pM)。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号